ClinicalTrials.gov
public full text
Public Domain
Novel Biomarker Assay for Biomarker Assay for HCC Detection
The primary purpose of this study is to assess the performance feasibility of Genetron's novel HCC liquid biopsy biomarkers assay for early detection. Piedmont Transplant Institute will provide a longitudinally collected blood sample from all HCC cases (mixture of early and advanced stage HCC) and cirrhosis control to Genetron Health after obtaining informed consent.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers#1138575
- HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B#1032605
- Different Genetic Features Associated With Hepatic Carcinogenesis#869651
- Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis#1053040
- ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing#1010606
Record · ID 911914
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive